Blood Clot Retrieval Devices Market Report 2025

The blood clot retrieval devices market size has grown rapidly in recent years. It will grow from $2.01 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 17.7%. The growth during the historic period is linked to the increasing prevalence of ischemic stroke, rising adoption of minimally invasive procedures, growing awareness about stroke management, higher healthcare expenditure, and an expanding elderly population.

The blood clot retrieval devices market size is expected to see rapid growth in the next few years. It will grow to $4.48 billion in 2029 at a compound annual growth rate (CAGR) of 17.3%. The growth projected for the forecast period is driven by the growing incidence of cardiovascular diseases, increasing demand for advanced neurovascular treatments, rising investments in healthcare infrastructure, greater focus on early stroke diagnosis, and higher patient preference for minimally invasive therapies. Primary trends during the forecast period include advancements in clot retrieval technologies, integration of advanced imaging for stroke diagnosis, innovations in minimally invasive neurovascular devices, incorporation of artificial intelligence in stroke treatment systems, and development of catheter-based retrieval systems.

The increase in stroke cases is expected to drive growth in the market for blood clot retrieval devices. Stroke occurs when blood flow to part of the brain is blocked or reduced, depriving brain tissue of oxygen and nutrients. This rise in stroke is largely due to an aging population, as older individuals are more prone to hypertension and vascular issues that raise stroke risk. Blood clot retrieval devices assist stroke patients by quickly removing clots blocking brain arteries, restoring circulation and lowering the chance of permanent disability. For example, in May 2024, the Centers for Disease Control and Prevention reported approximately 795,000 strokes annually in the United States. Consequently, the growing number of stroke cases is fueling demand for blood clot retrieval devices.

Leading companies in the blood clot retrieval devices market are developing advanced products such as dual-mechanism thrombectomy systems to enhance clot removal and reduce complications during procedures. These systems combine mechanical extraction and suction techniques within one device to effectively remove both acute and chronic clots, prevent clot migration, and decrease the necessity for multiple treatments. For instance, in March 2025, Inari Medical Inc. introduced the Artix Thrombectomy System, a dual-mechanism arterial thrombectomy device designed for various arterial clots. It integrates aspiration and mechanical extraction in a single operation and includes features such as an over-the-wire mechanical component, a kink-resistant sheath with a low profile, and a covered nitinol mesh funnel to limit clot migration. This device aims to offer doctors enhanced control and flexibility, allowing efficient removal of different clot types while maintaining vessel access throughout the procedure.

In February 2025, Stryker, a medical technology company based in the United States, acquired Inari Medical for an undisclosed sum. This acquisition is intended to broaden Stryker’s interventional endovascular portfolio, increase its foothold in the expanding peripheral vascular and venous thromboembolism treatment sectors, and utilize Inari Medical’s cutting-edge mechanical thrombectomy technology to improve patient outcomes globally. Inari Medical specializes in blood clot retrieval devices.

Major players in the blood clot retrieval devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., Surmodics Inc., AngioDynamics Inc., B. Braun Melsungen AG, Acandis GmbH, Phenox GmbH, Rapid Medical Ltd., Argon Medical Devices Inc., Shape Memory Medical Inc., Vesalio Inc.

North America was the largest region in the blood clot retrieval devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in blood clot retrieval devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the blood clot retrieval devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Blood clot retrieval devices are specialized medical tools designed to remove blood clots from blood vessels, particularly in cases of ischemic stroke. They restore normal blood flow by mechanically capturing and extracting the clot. These devices are typically employed in emergency procedures to reduce brain damage and improve patient outcomes.

The primary types of blood clot retrieval devices include mechanical embolus removal devices, Penumbra blood clot retrieval devices, stent retrievers, aspiration devices, and ultrasound-assisted devices. Mechanical embolus removal devices are minimally invasive tools that physically extract blood clots from vessels to rapidly restore blood flow. Technologies used include mechanical thrombectomy, chemical thrombectomy, ultrasound-assisted thrombectomy, and laser-assisted thrombectomy. Applications cover ischemic stroke, hemorrhagic stroke, pulmonary embolism, deep vein thrombosis, transient ischemic attack, and other types of strokes. These devices are applied in coronary arteries, peripheral arteries, and cerebral arteries. Key end users include hospitals, diagnostic centers, specialty clinics, ambulatory surgical centers, and other healthcare facilities.

The blood clot retrieval devices market research report is one of a series of new reports that provides blood clot retrieval devices market statistics, including blood clot retrieval devices industry global market size, regional shares, competitors with the blood clot retrieval devices market share, blood clot retrieval devices market segments, market trends, and opportunities, and any further data you may need to thrive in the blood clot retrieval devices industry. This blood clot retrieval devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood clot retrieval devices market consists of revenues earned by entities by providing services such as manufacturing and supplying clot retrieval devices, offering clinical training and procedural support, conducting research and technological innovation, assisting with regulatory approvals and market access. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood clot retrieval devices market also includes sales of mechanical thrombectomy devices, aspiration catheters, and stent retrievers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.